VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,698,428 | -11.0% | 992,138 | -0.4% | 0.02% | -12.0% |
| Q2 2023 | $30,005,823 | -21.5% | 996,540 | -16.0% | 0.02% | -24.2% |
| Q1 2023 | $38,219,667 | +22.6% | 1,186,555 | +5.1% | 0.03% | +17.9% |
| Q4 2022 | $31,179,934 | +33.7% | 1,128,733 | +7.1% | 0.03% | +21.7% |
| Q3 2022 | $23,329,000 | -13.2% | 1,054,176 | +6.2% | 0.02% | -11.5% |
| Q2 2022 | $26,889,000 | -39.7% | 992,921 | -14.6% | 0.03% | -31.6% |
| Q1 2022 | $44,598,000 | +64.3% | 1,162,932 | +37.2% | 0.04% | +72.7% |
| Q4 2021 | $27,147,000 | +6.2% | 847,541 | -2.3% | 0.02% | -4.3% |
| Q3 2021 | $25,569,000 | -45.2% | 867,629 | -36.9% | 0.02% | -45.2% |
| Q2 2021 | $46,692,000 | +68.7% | 1,374,101 | +61.3% | 0.04% | +50.0% |
| Q1 2021 | $27,678,000 | -3.8% | 851,639 | +2.6% | 0.03% | -12.5% |
| Q4 2020 | $28,782,000 | -45.9% | 829,888 | -38.9% | 0.03% | -52.2% |
| Q3 2020 | $53,223,000 | +9.3% | 1,359,126 | +2.4% | 0.07% | +3.1% |
| Q2 2020 | $48,698,000 | +76.1% | 1,327,662 | +10.6% | 0.06% | +47.7% |
| Q1 2020 | $27,660,000 | +8.2% | 1,200,537 | +34.8% | 0.04% | +37.5% |
| Q4 2019 | $25,553,000 | +0.6% | 890,612 | -6.4% | 0.03% | -8.6% |
| Q3 2019 | $25,411,000 | +48.1% | 951,355 | +41.7% | 0.04% | +40.0% |
| Q2 2019 | $17,160,000 | -0.0% | 671,379 | -15.2% | 0.02% | -3.8% |
| Q1 2019 | $17,161,000 | +27.7% | 791,474 | +13.1% | 0.03% | +13.0% |
| Q4 2018 | $13,438,000 | +70.0% | 700,051 | +64.0% | 0.02% | +91.7% |
| Q3 2018 | $7,906,000 | -28.6% | 426,865 | -16.4% | 0.01% | -36.8% |
| Q2 2018 | $11,069,000 | -13.1% | 510,895 | -11.9% | 0.02% | -17.4% |
| Q1 2018 | $12,741,000 | +8.6% | 579,650 | +4.2% | 0.02% | +4.5% |
| Q4 2017 | $11,733,000 | +14.3% | 556,532 | +24.5% | 0.02% | +4.8% |
| Q3 2017 | $10,262,000 | +21.9% | 446,963 | +17.2% | 0.02% | +16.7% |
| Q2 2017 | $8,420,000 | +12.7% | 381,351 | +16.4% | 0.02% | +5.9% |
| Q1 2017 | $7,473,000 | +9.7% | 327,611 | +0.6% | 0.02% | 0.0% |
| Q4 2016 | $6,811,000 | -65.9% | 325,566 | -56.9% | 0.02% | -68.5% |
| Q3 2016 | $19,946,000 | -8.2% | 754,685 | -3.8% | 0.05% | -20.6% |
| Q2 2016 | $21,739,000 | – | 784,524 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |